Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial DNA synthesis enzyme, primarily DNA polymerase III (DNA pol III), is a crucial enzyme complex responsible for replicating the bacterial genome during cell division. It catalyzes the addition of deoxyribonucleotides to a growing DNA strand in the 5' to 3' direction, using a template strand for guidance. Other enzymes, like DNA polymerase I, play supporting roles in primer removal and DNA repair. Due to its essential role in bacterial survival and its structural differences from eukaryotic counterparts (e.g. gyrase), it is a key target for antibacterial drug development.
Inhibition of DNA synthesis by targeting DNA polymerase III or related enzymes (e.g., DNA gyrase)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA Synthesis Enzyme (DNA).